Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Head and Neck Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Lung Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Tongue Neoplasms 1 Spondylitis, Ankylosing 1 Recurrence 1 Rectal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Liver Neoplasms 1 Hand-Foot Syndrome 1 Endometrial Neoplasms 1 Colon Cancer Stage 1 Bile Duct Neoplasms 1

Interventions

Sorafenib 9 Radiofrequency Ablation 7 Oxaliplatin 7 Fluorouracil 6 Doxorubicin 6 Neoadjuvant Therapy 5 toripalimab 4 lenvatinib 4 Injections 4 Chemotherapy, Adjuvant 4 pembrolizumab 3 Ultrasonography 3 Thalidomide 3 Leucovorin 3 Irinotecan 3 Cisplatin 3 Bevacizumab 3 tislelizumab 2 sintilimab 2 durvalumab 2 camrelizumab 2 anlotinib 2 Walking Speed 2 Standard of Care 2 Radiosurgery 2 Oncolytic Virotherapy 2 Metformin 2 Liver Transplantation 2 Laparoscopy 2 Immunohistochemistry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Liver Neoplasms × Celecoxib × Clear all

NCT03184493 2019-05-31

XBD

Guangxi Medical University

Phase 3 Unknown

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡